Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Warren Buffett's Berkshire Hathaway (NYSE:BRKa) disclosed its 13F filing for Q4 2024, revealing a notable investment in Constellation Brands (NYSE:STZ). The firm acquired 5.62 million Constellation shares, valued at $1.24 billion. Following the announcement, Constellation Brands stock surged 6% in after-hours trading, despite a 25.8% year-to-date decline.
Berkshire trimmed its stakes in major financial institutions. The company reduced its Citigroup (NYSE:C) holdings by 74%, lowering its position to 14.6 million shares. It also cut its Bank of America (NYSE:BAC) stake—formerly its second-largest holding—by 15%, bringing shares down to 680.2 million.
The report highlighted that Berkshire paused its Apple Inc (NASDAQ:AAPL) sell-off, maintaining 300 million shares, unchanged from Q3. This holding remains significantly lower than the 790 million shares owned at the end of 2023.
Additionally, Berkshire reduced its stake in DaVita HealthCare (NYSE:DVA) by approximately $32 million.
Investors closely monitor Berkshire's 13F filings, as Warren Buffett's long-term investment strategy influences market trends. Despite being 45 days old, the data offers insights into Berkshire's evolving portfolio and market outlook.
